This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Placzkowski, K. A. Articles by Service, F. J. Search for Related Content PubMed PubMed Citation Articles by Placzkowski, K. A. Articles by Service, F. J. Related Collections Diabetes and Insulin Endocrine Oncology

Secular Trends in the Presentation and Management of Functioning Insulinoma at the Mayo Clinic, 1987–2007

Division of Endocrinology and Metabolism (K.A.P., A.V., F.J.S.), Department of Medicine; Division of Gastroenterologic and General Surgery (G.B.T., C.S.G.); and Departments of Radiology (C.C.R., J.W.C., J.C.A.) and Laboratory Medicine and Pathology (R.V.L.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: F. John Service, M.D., Ph.D., Mayo Clinic, 200 First Street SW, Rochester Minnesota 55905. E-mail: service.john{at}mayo.edu.

Objective: The objective of the study was to assess changes in the presentation and diagnostic and radiological evaluation of patients with surgically confirmed insulinoma at the Mayo Clinic 1987–2007.

Methods: A retrospective analysis of patients with insulinoma was conducted. Patients with prior gastric bypass were excluded.

Results: A total of 237 patients [135 women (57%)] were identified. Hypoglycemia was reported solely in the fasting state in 73%, the fasting and postprandial state in 21%, and exclusively postprandially in 6%. There was a predominance of men in the postprandial symptom group. Considering the period of study by quartile, outpatient evaluation increased from 35 to 83% and successful preoperative localization improved from 74 to 100% comparing the first to the fourth quartiles. Although the rates of localization by noninvasive techniques remained static at approximately 75%, the addition of invasive modalities has resulted in successful preoperative localization in all patients in the past 10 yr. The sensitivity and specificity of the established diagnostic criteria using insulin, C-peptide, proinsulin, β-hydroxybutyrate, and glucose response to iv glucagon were greater than 90% and greater than 70%, respectively.

Conclusions: Although fasting hypoglycemia is characteristic of patients with insulinoma, postprandial symptoms have been reported with increasing, albeit low, frequency. Trends in the evaluation and preoperative management include a shift to outpatient diagnostic testing, an emphasis on successful preoperative localization to avoid blind pancreatic exploration, and a validation of the diagnostic criteria for hyperinsulinemic hypoglycemia.

This article has been cited by other articles:

				E. Christ, D. Wild, F. Forrer, M. Brandle, R. Sahli, T. Clerici, B. Gloor, F. Martius, H. Maecke, and J. C. Reubi Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4398 - 4405. [Abstract] [Full Text] [PDF]